正在為您準備內容...
正在為您準備內容...
成份 · Ingredient
利凡斯的明
利凡斯的明酒石酸鹽是一種可逆性膽鹼酯酶抑制劑，由利凡斯的明與(R,R)-酒石酸反應形成的酒石酸鹽。此藥物具有膽鹼能作用，主要用於治療神經退化性疾病。它能抑制乙醯膽鹼酯酶，增加腦部乙醯膽鹼濃度，具有神經保護作用。
Rivastigmine tartrate is a tartrate salt obtained by reaction of rivastigmine with one equivalent of (R,R)-tartaric acid. A reversible cholinesterase inhibitor. It has a role as an EC 3.1.1.8 (cholinesterase) inhibitor, a cholinergic drug and a neuroprotective agent. It contains a rivastigmine(1+).
| 藥品名稱 | 成份 | 號碼 |
|---|---|---|
| APO-RIVASTIGMINE CAP 1.5MG | HK-61654 | |
| APO-RIVASTIGMINE CAP 3MG | HK-61653 | |
| APO-RIVASTIGMINE CAP 4.5MG | HK-61652 | |
| APO-RIVASTIGMINE CAP 6MG | HK-61651 | |
| EXELON CAP 1.5MG | HK-43308 | |
| EXELON CAP 3MG | HK-43309 | |
| EXELON CAP 4.5MG | HK-43310 | |
| RIVASAN CAP 1.5MG | HK-60940 | |
| RIVASAN CAP 3MG | HK-60939 | |
| RIVASAN CAP 4.5MG | HK-60938 | |
| RIVASAN CAP 6MG | HK-60937 | |
| RIVASTIGMINE CAPSULES 1.5MG | HK-64710 | |
| RIVASTIGMINE CAPSULES 3MG | HK-64708 | |
| RIVASTIGMINE CAPSULES 4.5MG | HK-64716 | |
| RIVASTIGMINE CAPSULES 6MG | HK-64709 | |
| RIVASTON CAPSULES 1.5MG | HK-65969 | |
| RIVASTON CAPSULES 3MG | HK-65970 | |
| RIVASTON CAPSULES 4.5MG | HK-65972 | |
| RIVASTON CAPSULES 6MG | HK-65971 | |
| RIVETAL CAPSULES 1.5MG | HK-65628 |
藥品資料來源：香港衞生署藥物辦公室 · 化學資料來源：PubChem (NIH) · 資料僅供參考，不構成醫療建議